ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,129Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 288

$407K Total Retail Price of All Prescriptions

Rank: 117 out of 288

389 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 389 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 389 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 10,158 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
OMEPRAZOLE 578 518 1 3
AMLODIPINE BESYLATE 541 522 2 6
ATENOLOL 515 485 3 10
SIMVASTATIN 469 464 4 1
FUROSEMIDE 448 426 5 5
LEVOTHYROXINE SODIUM 398 397 6 2
WARFARIN SODIUM 304 302 7 9
LISINOPRIL 261 237 8 4
POTASSIUM CHLORIDE 253 248 9 11
METOPROLOL TARTRATE 250 250 10 8
HYDROCODONE-ACETAMINOPHEN 245 194 S3 11 7
HYDROCHLOROTHIAZIDE 199 182 12 13
LOSARTAN POTASSIUM 195 190 13 16
METFORMIN HCL 169 136 14 12
ATORVASTATIN CALCIUM 169 124 14 14
TRIAMTERENE-HCTZ 161 138 16 28
ENALAPRIL MALEATE 147 120 17 40
TAMSULOSIN HCL 144 131 18 24
ALLOPURINOL 140 139 19 23
DIGOXIN 134 132 20 51
POLYETHYLENE GLYCOL 3350 118 109 21 38
PREDNISONE 113 100 22 30
DONEPEZIL HCL 105 105 23 29
KLOR-CON 10 95 86 24 66
FLUOXETINE HCL 95 79 24 64
CIPROFLOXACIN HCL 93 89 26 62
CARVEDILOL 91 89 27 27
GLIMEPIRIDE 90 77 28 32
CLOPIDOGREL 88 77 29 47
GABAPENTIN 88 81 29 17
FAMOTIDINE 84 84 31 68
PLAVIX 81 76 32 71
AZITHROMYCIN 78 61 33 49
SPIRONOLACTONE 75 75 34 36
DILTIAZEM 24HR CD 70 70 35 75
FENTANYL 68 68 S2 36 57
SERTRALINE HCL 66 55 37 25
PROPRANOLOL HCL 66 55 37 90
FELODIPINE ER 65 54 39 132
PRAVASTATIN SODIUM 64 63 40 21
NAMENDA 61 61 41 39
ALENDRONATE SODIUM 60 60 42 20
ZOLPIDEM TARTRATE 59 59 43 22
RANITIDINE HCL 59 59 43 33
PROAIR HFA 57 32 45 45
FLUTICASONE PROPIONATE 56 33 46 41
FINASTERIDE 56 41 46 82
CEPHALEXIN 55 54 48 83
ROPINIROLE HCL 54 45 49 74
JANUVIA 54 41 49 88
ESCITALOPRAM OXALATE 50 50 51 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 18, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.